PROTEINANZEIGE

European patent · EP2516702 · In force

Register entry

Publication number
EP2516702
Application number
EP10838401
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 20, 2010
Published
Oct 31, 2012
Granted
Mar 21, 2018
Protection ends at the latest
Dec 19, 2030
Next annual fee due
Dec 31, 2026
IPC classes
C40B 30/04 (2006.01)
C40B 40/02 (2006.01)
C12N 15/10 (2006.01)
Priority
AU 2009906310 23.12.2009
PCT application
PCT/AU2010/001702 20.12.2010
PCT publication
WO2011/075761 30.06.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 9, 2024

    Change

    Published in Swissreg on 09.01.2024

  4. Jan 4, 2023

    Change

    Published in Swissreg on 04.01.2023

  5. Apr 20, 2018

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 20.04.2018

  6. Mar 21, 2018

    Granted

    Published in Swissreg on 21.03.2018

Parties

Holder

Affinity Biosciences Pty Ltd

1 Dalmore Drive, Scoresby, VIC 3179, AU

Agent

MICHELI & CIE SA

122, Rue de Genève Case postale 61, 1226 Thônex

Inventor

BEASLEY, Matthew

Fitzroy North Victoria 3068, AU

KIEFEL, Ben

Mitcham Victoria 3132, AU

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.